Skip to main content
Organic and Medicinal Chemistry Letters logoLink to Organic and Medicinal Chemistry Letters
. 2013 Dec 17;3:12. doi: 10.1186/2191-2858-3-12

Correction: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase

Ashok Penta 1, Swastika Ganguly 2, Sankaran Murugesan 1,
PMCID: PMC3878780  PMID: 24342137

It has been drawn to the publisher’s attention that this article [1] was inadvertently published with certain omissions. The authors apologize for the omissions in the published article.

The co-authors Nicolas Sluis-Cremer and Brian D. Herman, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA have now been added as co-authors.

The following sentence has been added to the acknowledgements section: “The research in the N.S.–C laboratory was supported by a grant from the United States of America National Institutes of Health (GM068406)”

Contributor Information

Ashok Penta, Email: penta.ashok@gmail.com.

Swastika Ganguly, Email: swastikaganguly@bitmesra.ac.in.

Sankaran Murugesan, Email: murugesaa789@gmail.com.

References

  1. Penta. et al. Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase. Organic and Medicinal Chemistry Letters. 2013;3:8. doi: 10.1186/2191-2858-3-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Organic and Medicinal Chemistry Letters are provided here courtesy of Springer-Verlag

RESOURCES